Takayasu's arteritis.
This paper reviews the literature of Takayasu's arteritis (T.A.). The concept of this disease has evolved considerably over the past decades. T.A. was first described by Mikito Takayasu in 1908, and was thought to be restricted to south-east Asia. But due to the increasing reports from all over the world, it is well established that T.A. has world-wide distribution. Clinical presentation varies according to the location of the arterial lesions. In Europe brachiocephalic trunk lesions prevail and are best managed by an arterial reconstruction. Historical background, epidemiology, etiology, pathology, clinical findings, diagnosis, classification, treatment and long-term prognosis are discussed.
Désiron
Q
Q
Department of Cardiovascular Surgery, University Hospital of Liège (CHU Sart-Tilman), Belgium.
Zeaiter
R
R
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001707:Biopsy, Needle; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011379:Prognosis; D013625:Takayasu Arteritis / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014656:Vascular Surgical Procedures
D000305:Adrenal Cortex Hormones